A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD.

Nair, Suresh; Thomas, Enson; Pearson, Stanley B; Henry, Michael T

Nair, Suresh; Thomas, Enson; Pearson, Stanley B; Henry, Michael T.

Affiliation

Nair S; Department of Respiratory Medicine, Leeds General Infirmary, Leeds LS1 3EX, UK.

Chest ; 128(1): 48-54, 2005 Jul.

Article in En | MEDLINE | ID: mdl-16002915

Subject(s)

Albuterol/administration & dosage; Bronchodilator Agents/administration & dosage; Pulmonary Disease, Chronic Obstructive/drug therapy; Acute Disease; Aged; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Pulmonary Disease, Chronic Obstructive/physiopathology; Statistics, Nonparametric; Treatment Outcome

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Bronchodilator Agents / Pulmonary Disease, Chronic Obstructive / Albuterol Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links